Fund HoldingsForesite Capital Management IV, LLC

Total Portfolio Value
$290.15M
Total Bought
$46.76M
Total Sold
$29.10M
Net Transaction
+$17.67M
Filing Period:
Securities
SharesValue ($K)
Q1 2026
Q2 2026
Change
Q1 2026
Q2 2026
Weight (%)
Change
Pharvaris N.V.
COM
4,778,5814,778,5810134,995165,24356.95%+30,248
CYTOKINETICS INC(CYTK)503,295714,695+211,40033,17260,88520.98%+27,713
Relay Therapeutics, Inc.(RLAY)1,000,0001,250,000+250,0009,95023,3888.06%+13,438
Crinetics Pharmaceuticals, Inc.(CRNX)0150,000+150,00005,6131.93%+5,613
Eikon Therapeutics, Inc.1,943,6821,943,682020,56425,3658.74%+4,801
Xenon Pharmaceuticals Inc.(XENE)160,000160,00009,3049,6583.33%+354
Maze Therapeutics, Inc.(MAZE)156,9010-156,9014,6830-4,683
Alector, Inc.3,887,2000-3,887,2008,3570-8,357
Lyell Immunopharma, Inc.800,3990-800,39916,0560-16,056
Page 1 of 1